Tanaka J - Search Results

1

Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.

Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T, Tanaka J, Fujii Y, Kobayashi M, Kasai M, et al. Imamura M, et al. Among authors: tanaka j. Bone Marrow Transplant. 1994 Jun;13(6):745-51. Bone Marrow Transplant. 1994. PMID: 7920309

2

The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease.

Tanaka J, Imamura M, Kasai M, Hashino S, Kobayashi S, Noto S, Higa T, Sakurada K, Asaka M. Tanaka J, et al. Bone Marrow Transplant. 1997 Mar;19(6):571-6. doi: 10.1038/sj.bmt.1700708. Bone Marrow Transplant. 1997. PMID: 9085737

3

Low levels of serum soluble c-kit relates to delayed engraftment after bone marrow transplantation.

Hashino S, Imamura M, Tanaka J, Kobayashi S, Kasai M, Sakurada K, Asaka M. Hashino S, et al. Among authors: tanaka j. Leuk Lymphoma. 1997 Apr;25(3-4):327-31. doi: 10.3109/10428199709114172. Leuk Lymphoma. 1997. PMID: 9168443

4

Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.

Kobayashi S, Imamura M, Hashino S, Tanaka J, Asaka M. Kobayashi S, et al. Among authors: tanaka j. Leuk Lymphoma. 1997 Dec;28(1-2):159-69. doi: 10.3109/10428199709058342. Leuk Lymphoma. 1997. PMID: 9498715

5

Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.

Mori A, Hashino S, Imamura M, Kahata K, Kawakami H, Shibata M, Kobayashi S, Tanaka J, Asaka M. Mori A, et al. Among authors: tanaka j. Bone Marrow Transplant. 1998 Mar;21(6):615-7. doi: 10.1038/sj.bmt.1701130. Bone Marrow Transplant. 1998. PMID: 9543066

6

Possible role of granulocyte colony-stimulating factor in increased serum soluble interleukin-2 receptor-alpha levels after allogeneic bone marrow transplantation.

Kobayashi S, Imamura M, Hashino S, Noto S, Mori A, Tanaka J, Naohara T, Kasai M, Asaka M. Kobayashi S, et al. Among authors: tanaka j. Leuk Lymphoma. 1999 May;33(5-6):559-66. doi: 10.3109/10428199909058460. Leuk Lymphoma. 1999. PMID: 10342583

7

Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.

Tanaka J, Mori A, Ohta S, Yamamoto Y, Kobayashi S, Hashino S, Kobayashi M, Asaka M, Imamura M. Tanaka J, et al. Br J Haematol. 2000 Mar;108(4):778-83. doi: 10.1046/j.1365-2141.2000.01938.x. Br J Haematol. 2000. PMID: 10792283 Free article.

8

T-cell co-signalling molecules in graft-versus-host disease.

Tanaka J, Asaka M, Imamura M. Tanaka J, et al. Ann Hematol. 2000 Jun;79(6):283-90. doi: 10.1007/s002779900134. Ann Hematol. 2000. PMID: 10901605 Review.

9

Proliferation of CD4+ lymphocytes in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Hashino S, Mori A, Kobayashi S, Tanaka J, Musashi M, Asaka M, Imamura M. Hashino S, et al. Among authors: tanaka j. Int J Hematol. 2000 Jun;71(4):389-93. Int J Hematol. 2000. PMID: 10905061

10

Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease.

Tanaka J, Tutumi Y, Mori A, Ohta S, Kobayashi S, Asaka M, Imamura M. Tanaka J, et al. Bone Marrow Transplant. 2000 Aug;26(3):287-90. doi: 10.1038/sj.bmt.1702511. Bone Marrow Transplant. 2000. PMID: 10967567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,217 results

Search Page

Filters